SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
F-3	Registration statement for certain foreign private issuers offered for certain transactions	Mar 28, 2006	View HTML 0000950123-06-003806.pdf 0000950123-06-003806.rtf 0000950123-06-003806.xls
F-3	Registration statement for certain foreign private issuers offered for certain transactions	Mar 28, 2006	View HTML 0000950123-06-003805.pdf 0000950123-06-003805.rtf 0000950123-06-003805.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Mar 23, 2006	View HTML 0001144204-06-011298.pdf 0001144204-06-011298.rtf 0001144204-06-011298.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Mar 21, 2006	View HTML 0001144204-06-010860.pdf 0001144204-06-010860.rtf 0001144204-06-010860.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Mar 20, 2006	View HTML 0001144204-06-010649.pdf 0001144204-06-010649.rtf 0001144204-06-010649.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Mar 17, 2006	View HTML 0001144204-06-010406.pdf 0001144204-06-010406.rtf 0001144204-06-010406.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Mar 16, 2006	View HTML 0001144204-06-010150.pdf 0001144204-06-010150.rtf 0001144204-06-010150.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Mar 16, 2006	View HTML 0001144204-06-010166.pdf 0001144204-06-010166.rtf 0001144204-06-010166.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Mar 02, 2006	View HTML 0001144204-06-008364.pdf 0001144204-06-008364.rtf 0001144204-06-008364.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Feb 23, 2006	View HTML 0001144204-06-007372.pdf 0001144204-06-007372.rtf 0001144204-06-007372.xls

Data provided by Kaleidoscope.